Search research articles
Contact Us
Filters
Showing results (321-330 of 345) with videos related to
Page
of 35
Sort By:
Plos One
|
July 27, 2011
Large scale comparison of innate responses to viral and bacterial pathogens in mouse and macaque
Guy Zinman, Rachel Brower-Sinning, Chineye H Emeche, et al.
Frontiers in Immunology
|
April 23, 2020
Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools
Anne S De Groot, Leonard Moise, Frances Terry, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
May 20, 2025
Broadly active intranasal influenza vaccine with a nanocomplex particulate adjuvant targeting mast cells and toll-like receptor 9
Luis Ontiveros-Padilla, Dylan A Hendy, Erik S Pena, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 13, 2020
Glycomic analysis of host response reveals high mannose as a key mediator of influenza severity
Daniel W Heindel, Sujeethraj Koppolu, Yue Zhang, et al.
Vaccine
|
September 17, 2025
Gene discovery and expression analysis of the B cell receptor repertoire in the domestic ferret model
Luke S Hebert, Whitney Pickens, Ed Satterwhite, et al.
Science Translational Medicine
|
February 4, 2021
Development and deployment of COVID-19 vaccines for those most vulnerable
Wayne C Koff, Theodore Schenkelberg, Tere Williams, et al.
Vaccine
|
January 16, 2026
Erratum to "Gene discovery and expression analysis of the B cell receptor repertoire in the domestic ferret model" [Vaccine 64 (2025) 127725]
Luke S Hebert, Whitney Pickens, Ed Satterwhite, et al.
The Lancet. Infectious Diseases
|
April 20, 2026
Measuring population immunity against influenza using individual antibody titres: a multicountry, retrospective observational study
Weijia Xiong, Xiaotong Huang, Tran Thi Nhu Thao, et al.
Biorxiv : the Preprint Server for Biology
|
January 5, 2021
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions and monocytes for optimal therapeutic protection
Emma S Winkler, Pavlo Gilchuk, Jinsheng Yu, et al.
Cell
|
March 10, 2021
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection
Emma S Winkler, Pavlo Gilchuk, Jinsheng Yu, et al.
Page
of 35
Search research articles
Search
Showing results (321-330 of 345) with videos related to
Sort By:
Page
of 35
Plos One
|
July 27, 2011
Large scale comparison of innate responses to viral and bacterial pathogens in mouse and macaque
Guy Zinman, Rachel Brower-Sinning, Chineye H Emeche, et al.
Frontiers in Immunology
|
April 23, 2020
Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools
Anne S De Groot, Leonard Moise, Frances Terry, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
May 20, 2025
Broadly active intranasal influenza vaccine with a nanocomplex particulate adjuvant targeting mast cells and toll-like receptor 9
Luis Ontiveros-Padilla, Dylan A Hendy, Erik S Pena, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 13, 2020
Glycomic analysis of host response reveals high mannose as a key mediator of influenza severity
Daniel W Heindel, Sujeethraj Koppolu, Yue Zhang, et al.
Vaccine
|
September 17, 2025
Gene discovery and expression analysis of the B cell receptor repertoire in the domestic ferret model
Luke S Hebert, Whitney Pickens, Ed Satterwhite, et al.
Science Translational Medicine
|
February 4, 2021
Development and deployment of COVID-19 vaccines for those most vulnerable
Wayne C Koff, Theodore Schenkelberg, Tere Williams, et al.
Vaccine
|
January 16, 2026
Erratum to "Gene discovery and expression analysis of the B cell receptor repertoire in the domestic ferret model" [Vaccine 64 (2025) 127725]
Luke S Hebert, Whitney Pickens, Ed Satterwhite, et al.
The Lancet. Infectious Diseases
|
April 20, 2026
Measuring population immunity against influenza using individual antibody titres: a multicountry, retrospective observational study
Weijia Xiong, Xiaotong Huang, Tran Thi Nhu Thao, et al.
Biorxiv : the Preprint Server for Biology
|
January 5, 2021
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions and monocytes for optimal therapeutic protection
Emma S Winkler, Pavlo Gilchuk, Jinsheng Yu, et al.
Cell
|
March 10, 2021
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection
Emma S Winkler, Pavlo Gilchuk, Jinsheng Yu, et al.
Page
of 35